Superbug surcharge: The economics of MDROs and HAIs
Multidrug-resistant organisms (MDROs) and healthcare-associated infections (HAIs) threaten patient health and impose significant financial burdens on healthcare systems, necessitating extended hospital stays and costly treatments.
Advancements in screening, detection, and treatment options can help healthcare facilities control the costs and impact of MDROs and HAIs, leading to better patient outcomes.
Download the Superbug surcharge: The economics of MDROs and HAIs infographic to discover:
- The global cost of treating MDRO carbapenem-resistant Acinetobacter baumannii plus recurrent Clostridioides difficile (C. diff) infections
- The global predicted cost in 2025 of Antimicrobial resistance (AMR), including MDROs
- How the variety of tools from Thermo Fisher Scientific can help combat MDROs/HAIs, tools such as:
- Thermo Scientific™ Brilliance™ and Spectra™ Chromogenic Media,
- Thermo Scientific™ Sensititre™ AST System,
- Thermo Scientific™ Oxoid™ AST Discs,
- Thermo Scientific™ Culti-Loops™ Quality Control Organisms
Please note : Any products described on this page are
for Research Use Only and not intended for clinical diagnostic procedures unless otherwise stated.
